0001181431-14-030477.txt : 20140828
0001181431-14-030477.hdr.sgml : 20140828
20140828195424
ACCESSION NUMBER: 0001181431-14-030477
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140826
FILED AS OF DATE: 20140828
DATE AS OF CHANGE: 20140828
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MEDIVATION, INC.
CENTRAL INDEX KEY: 0001011835
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 133863260
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
BUSINESS PHONE: 415-543-3470
MAIL ADDRESS:
STREET 1: 525 MARKET STREET
STREET 2: 36TH FLOOR
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94105
FORMER COMPANY:
FORMER CONFORMED NAME: ORION ACQUISITION CORP II
DATE OF NAME CHANGE: 19960408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Seely Lynn
CENTRAL INDEX KEY: 0001327111
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-32836
FILM NUMBER: 141073088
MAIL ADDRESS:
STREET 1: 501 2ND STREET
STREET 2: SUITE 211
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94107
4
1
rrd415199.xml
SEELY -- 8/26/14 EXERCISE AND SALE
X0306
4
2014-08-26
0
0001011835
MEDIVATION, INC.
MDVN
0001327111
Seely Lynn
C/O MEDIVATION, INC.
525 MARKET ST., 36TH FLOOR
SAN FRANCISCO
CA
94105
0
1
0
0
Chief Medical Officer
Common Stock
2014-08-26
4
M
0
5700
10.585
A
64722
D
Common Stock
2014-08-26
4
S
0
5700
88.953
D
59022
D
Common Stock
2014-08-27
4
M
0
14300
10.585
A
73322
D
Common Stock
2014-08-27
4
S
0
11700
89.43
D
61622
D
Common Stock
2014-08-27
4
S
0
2600
90.42
D
59022
D
Stock Option (Right to Buy)
10.585
2014-08-26
4
M
0
5700
0.00
D
2017-10-01
Common Stock
5700
194300
D
Stock Option (Right to Buy)
10.585
2014-08-27
4
M
0
14300
0.00
D
2017-10-01
Common Stock
14300
180000
D
Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices ranging from $88.95 to $89.06. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.
The shares were sold at prices ranging from $89.00 to $89.97. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $90.01 to $90.95. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Jennifer Rhodes, Attorney-in-fact
2014-08-27